Rating History for Lyell Immunopharma (LYEL) by H.C. Wainwright

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/9/2026 Mitchell S. Kapoor Maintain Buy
(Buy)
45.00
(N/A)
 
 
  Details